www.epmmagazine.com
day thousands of litres at a time, like their monoclonal antibody counterparts, so from a supplier point of view we have to think differently in how we cater for their needs. This area is of particular interest to me as there is a lot of space for innovation and creativity, they are forcing us to think outside of the box to satisfy their processing requirements. With all the conversation about artificial intelligence (AI), I’m also interested to see how this will be implemented in companies such as ours in the future. IN FIVE YEARS TIME WHAT WOULD YOU LIKE TO SEE HAPPEN WITHIN YOUR INDUSTRY? Five years is such a short time in the world of pharma and biotech but there are some changes already in progress. Engineering at a professional level is still considered quite elitist so it is great to see the industry actively trying to engage and inspire young people from a wider variety of social backgrounds. Events such as INWED and organisations like the Women’s Engineering Society (WES) are already doing fantastic work in this area, so I look forward to seeing these grow and develop, and working with Watson-Marlow to encourage more people from all backgrounds to pursue careers in engineering.
I therefore think the promotion of female role models across the wide-ranging industry is hugely important.
11